THE NEW CHALLENGES FACED BY THE PHARMACEUTICAL INDUSTRY IN CONSIDERING THE IMPACT AND IMPLEMENTATION OF THE HUMAN GENOME PROJECT TO FUTURE DRUG DEVELOPMENT